• Tidak ada hasil yang ditemukan

Adrenal Glands 1. Embryology

ENDOCRINE SYSTEM

E. Adrenal Glands 1. Embryology

a. The adrenal glands develop from two differ­

ent origins: the cortex, arising from the mesoderm, and the medulla, arising from the neuroectoderm and is found above the much smaller kidney by 8 weeks of gestation. Differentiation of the

adrenal medulla occurs late in development. The zona reticularis is not developed until the end of the third year of life and is not fully developed until around 15 years of age. The mesoderm is involved in the development of the gonads (Miller & Flück, 2014).

b. Fetal cortisol is necessary as a fetus prepares for extrauterine transition. An increase in fetal cortisol occurs in the last 10 weeks of gestation and prepares several systems that are critical for survival. As delivery approaches, cortisone, the active form that would be detrimental in early fetal development, is converted by the liver and lung tissues to cortisol (Dattani & Gevers, 2016).

Cortisol progressively decreases during the first 2 months of life.

c. Early in the fetus’s development, there is no epinephrine. Norepinephrine is the dominant cat­

echolamine at birth (Miller & Flück, 2014).

2. Location. The adrenal glands are small glands that lie atop the kidneys. Each gland has two distinct parts, the cortex, constituting 80% of the gland, and the medulla, constituting 20% of the gland (Babler et al., 2013).

3. Anatomic Structure. The adrenal gland is sur­

rounded by a fibrous capsule. The adrenal cor­

tex has three histologically different zones: zona glomerulosa,  the outermost layer, which constitutes 15% of the cortex; zona fasciculate, the middle layer, which constitutes 75% of the cortex; and the zona reticularis, the innermost layer, constituting 10% of the cortex. The adrenal medulla has sympathetic and parasympathetic innervation but the adre­

nal cortex does not. The adrenal circulation unlike other organs does not run in parallel. Arterial blood supplied by smaller arteries and flows toward the medulla, so medullary chromaffin cells see high steroid concentration in their circulation. The more conventional veins drain into the left renal vein and the vena cava (Miller & Flück, 2014).

4. Cell Types (Miller & Flück, 2014)

a. The adrenal cortex is responsible for the secre­

tion of corticosteroids, which are synthesized from cholesterol. These hormones are released from three separate zones in the adrenal cortex. The three zones each secrete unique hormones and from the outside to inside they are often remem­

bered by saying salt, sugar, and sex.

i. The zona glomerulosa is responsible for the secretion of mineralocorticoid and aldosterone.

ii. The zona fasciculata is responsible for secreting glucocorticoids, mainly cortisol and a small amount of androgen secretion.

iii. The zona reticularis is responsible for secreting androgen, estrogen, and small amounts of glucocorticoid.

b. The chromaffin cells are the major cells of the adrenal medulla and they store the catecholamines epinephrine and norepinephrine as secretory granules. They are synthesized from phenylala­

nine with innervation from the parasympathetic and sympathetic nervous systems. In times of stress, exocytosis occurs after depolarization from

acetylcholine, and enhanced amounts of hor­

mones are released (Brashers et al., 2014).

5. Aldosterone (Figure 6.9)

a. Biosynthesis. Aldosterone is the most potent mineralcorticoid and it is imperative for life functions due to its sodium­retaining proper­

ties. It is a steroid compound synthesized from cholesterol absorbed from the blood. Synthesis begins in the zona fasciculata and reticularis with final conversion to active form in the zona glomerulosa (Brashers et al., 2014).

b. Regulation. It occurs primarily by angioten­

sin II via the renin–angiotensin system, but it is

Stimulates posterior pituitary gland

Increased ADH secretion

Fight-or-Flight Reaction (increased heart rate, blood pressure, and glucose concentration)

Aldosterone Effects:

• Increased sodium and water reabsorption (sodium and water retention)

Stimulates sympathetic centers and adrenal medulla

Stimulates limbic lobe and other part of

cerebral cortex Stimulates

hypothalamus

Releases increased amounts of CRH

Stimulates anterior pituitary

gland to secrete increased amounts

of ACTH

Stimulates Adrenal Cortex:

• Marked increase of glucocorticoids (cortisol) secretion

• Moderate increase of mineralocorticoids (aldosterone) secretion

Cortisol Effects:

• Increased catabolism of tissue proteins, gluconeogenesis, producing hyperglycemia

• Decreased lymphocytes and immune responses

• Decreased eosinophils and allergic responses

Stress

Caused by real or perceived negative physiological, emotional, or cognitive stimuli

Increased catecholamines levels

(norepinephrine and epinephrine) in blood

Antidiuresis (decreased urine and water

retention)

Increased Blood Volume

Neuropeptide Y:

Vasoconstriction;

platelets aggregation;

vascular smooth muscle hypertrophy

FIGURE 6.9 Cortisol and aldosterone effects during stress.

ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone; CRH, corticotropin- releasing hormone.

DEVELOPMENTAL ANATOMY AND PHYSIOLOGY 501

also activated for release by volume depletion, decreased renal perfusion, ACTH and sodium levels, and hyperkalemia. A small increase in serum potassium will triple aldosterone release.

This response is imperative for the prevention of the serious cardiotoxic effects brought about by hyperkalemia. Inhibition of aldosterone release occurs secondary to volume expansion, hypo­

kalemia, and low angiotensin levels (Brashers et al., 2014; Hall, 2016).

c. Effects. Aldosterone is responsible for 90%

of mineralocorticoid activity (Hall, 2016). It acts on the distal tubule, collecting tubule, and col­

lecting duct of the kidney to promote sodium reabsorption and potassium excretion. Along with renal reabsorption of sodium, there is a concurrent movement of water into the vascular bed. The net effect is an increase in extracellu­

lar sodium, an increase in extracellular vol­

ume, and a decrease in extracellular potassium.

Aldosterone promotes reabsorption of sodium and excretion of potassium by the sweat and salivary glands, which promotes hydrogen ion excretion by the kidney and sodium absorption by the intestines. If aldosterone is low or absent, bowel absorption of sodium and water will not occur and diarrhea will result (Brashers et al., 2014; Hall, 2016).

d. Role in critical illness. Aldosterone is key to maintenance of extracellular volume. Excess release can have lasting effects of more than 1 to 2 days with notable increase in arterial blood pressure. A subsequent natriuresis occurs, which increases the excretion of both water and sodium, and once it normalizes the pressure will return to the previous level (volume rise of 5%–15%

causes blood pressure rise of 15–25  mmHg;

Hall, 2016).

6. Cortisol (Figure 6.9)

a. Biosynthesis. Cortisol is a steroid compound derived mostly from cholesterol and is the main product excreted by the adrenal cortex (Miller &

Flück, 2014). It is the most potent of the glucocor­

ticoids and has a half­life of 90 minutes (Brashers et al., 2014).

b. Regulation. The primary stimulus for secre­

tion of cortisol is ACTH, but stress is another strong stimulus. Release of cortisol is inhibited by negative feedback to either the hypothalamus or the anterior pituitary secondary to increased cortisol levels, which produces a decrease in CRH release in the hypothalamus or decrease in ACTH release in the anterior pituitary (Brashers et al., 2014).

c. Secretion. Secretion is regulated by the hypo­

thalamus and anterior pituitary. It is released immediately after stimulation from ACTH. It has a diurnal rhythm release with ACTH and peaks in the hours just before awakening. It circulates bound to albumin, the glycoprotein cortisol- binding globulin (CBG; also known as transcortin) or in the unbound active form (Brashers et al., 2014). Transcortin serves an important role in the negative feedback loop for cortisol and is ele­

vated when estrogen levels are high (Clayton &

McCance, 2014).

d. Effects. Cortisol is responsible for 95% of glu­

cocorticoid activity and is necessary in life for stress protection (Hall, 2016). Cortisol increases gluconeogenesis and glycogenolysis to provide a substrate for this stressful time, often leading to hyperglycemia. Protein synthesis decreases, and catabolism of protein increases. Cortisol promotes mobilization of fatty acids from the tis­

sues. An anti­inflammatory cascade occurs with its release that counteracts and modulates the body’s immune response and endothelial integ­

rity. Cortisol is potentiated by nitric oxide and it also provides vascular tone to increase blood pressure and prevent capillary leak (Brashers et al., 2014; Levy­Shraga & Pinhas­Hamiel, 2013).

e. Role in critical illness. Absolute AI is rare.

Relative AI, in which cortisol production is inad­

equate to the level of stressful stimuli, can be seen in sepsis, trauma, or surgery (Levy­Shraga  &

Pinhas­Hamiel, 2013). Critical illness-related cor- ticosteroid insufficiency (CIRCI) will be discussed later in the chapter.

7. Abnormalities of Adrenal Cortical Function

a. AI results in insufficient glucocorticoid and mineralocorticoid release or production and will require the child to have lifelong administration of exogenous hormones. It presents in childhood primarily as congenital adrenal hyperplasia (CAH) or Addison’s disease. CAH is an auto­

somal recessive congenital disorder and is the leading cause of AI in childhood (Webb & Krone, 2015). It usually presents in the newborn period with symptoms of shock, ambiguous genitalia, and the very diagnostic electrolyte abnormal­

ities of hyponatremia and hyperkalemia. It has many variants that explain the specific present­

ing symptoms and is now part of the newborn screen with a 17­hydroxy progesterone level (White, 2016). Addison’s disease is a rare autoim­

mune or infectious process in children. It results from an absent or damaged adrenal gland.

The deficiency produces initial weakness with

weight loss, hyperpigmentation, dehydration, electrolyte imbalances, and altered metabolism (Brashers et al., 2014). The presentation may progress and lead to adrenal crisis with hypo­

tension and cardiovascular collapse. Children present in shock due to the acute depletion of adrenal cortical hormones. It is precipitated by vomiting, diarrhea, convulsions, coma, hypoten­

sion, hyperpyrexia, tachycardia, and cyanosis.

AI can also result from exogenous suppression of hormones with oral or intravenous (IV) ste­

roids, as well as an abrupt withdrawal of ste­

roids after chronic use (White, 2016). Children who suffer from severe sepsis, are premature or less than 6 months of age, and those who have had etomidate administration are at higher risk for adrenal sufficiency.

b. Hyperfunction of the adrenal cortex, or Cushing syndrome, is a rare disorder in children resulting in excess cortisol. Excess cortisol can be rarely caused by a pituitary adenoma but more common causes include administration of high dose of exogenous steroids or chronic use of steroids (Brashers et al., 2014). The very typical “Cushingoid” effects include weight gain, moon facies, truncal striae, atropy of skin or bruising, emotional lability, hyperglycemia, and high blood pressure (Brashers et al., 2014).

With long­term steroid excess, children will have problems with bone demineralization and stunted growth.

8. Epinephrine

a. Biosynthesis. Epinephrine is a catecholamine derived from the amino acid tyrosine, which is then converted to dopamine in the sympathetic nerve endings. Dopamine is converted to nor­

epinephrine, which is converted to epinephrine in the adrenal medulla. Epinephrine secretion is 80% of the total catecholamine secreted by the adrenal medulla and at rest it is released at 0.2 mcg/kg/min (Hall, 2016).

b. Regulation. Neuroendocrine (stress, fear, illness) stimulation causes epinephrine and norepinephrine to be directly released into the blood. Any stimulus that produces a sympa­

thetic response stimulates secretion of epineph­

rine. The effects are rapid but only seen for seconds to minutes (Brashers et al., 2014). ACTH and glucocorticoids also stimulate release of epi­

nephrine. Inhibition of epinephrine is through negative feedback loops; high levels of circulat­

ing catecholamines will produce downregula­

tion of sympathetic receptors.

c. Effects. Epinephrine stimulates the beta­

adrenergic receptors in the end organs. The greatest effect is due to stimulation of the sym­

pathetic beta­1­adrenergic receptors in the heart, resulting in increased cardiac contrac­

tility, conduction velocity, and heart rate. The net result is an increase in cardiac output and blood pressure. In isolation, stimulation of the beta­2­ adrenergic receptors of the vascular bed promotes relaxation; however, during stress the vasoconstricting effects of norepinephrine coun­

teract significant vasodilation. Other effects of stimulation of the beta­2­adrenergic receptors are intestinal, bladder and uterine relaxation, and bronchial dilation. Epinephrine increases metabolic activity to a much greater degree than norepinephrine. It increases glycogenolysis and glucose release, resulting in elevations of blood glucose to supply fuel substrates. Circulating epinephrine accounts for 10% of the sympathetic activity during the stress response (Hall, 2016).

d. Role in critical illness. Epinephrine is used for hypotension, cold shock, bradycardia, and asystole (Chameides, Samson, Schexnayder,  &

Hazinski, 2011). Cold shock states are char­

acterized by the presence of cold extremities, delayed capillary refill, and low cardiac output.

The actions of epinephrine are dose dependent.

At lower doses, epinephrine will have greater beta­2 adrenergic effect and SVR may fall whereas at higher doses alpha­adrenergic effects will be seen and SVR will rise (Davis et al., 2017).

9. Norepinephrine

a. Biosynthesis. Norepinephrine is synthesized from its precursor dopamine in the nerve end­

ings of the sympathetic nervous system with only minor sources from the medulla.

b. Regulation is the same as for epinephrine.

c. Effects are secondary to stimulation of the alpha­adrenergic receptors in the end organs.

The most significant effect during stress is peripheral vasoconstriction supporting blood pressure. Stimulation of the alpha­adrenergic receptors also produces dilation of the iris, con­

traction of the bladder and intestinal sphincters, and pilomotor contraction.

d. Role in critical illness. Norepinephrine is used in hypotensive, vasodilated, warm shock states (Chameides et al., 2011). Children with warm shock will have flash capillary refill;

warm, pink extremities; and bounding pulses.

Norepinephrine is used to reverse this low SVR

CLINICAL ASSESSMENT OF ENDOCRINE FUNCTION 503

state, which is characterized by a wide pulse pressure (when the diastolic pressure is half of the systolic; Davis et al., 2017).

10. Hyperfunction of adrenal medulla is rare, and is most often caused by a catecholamine­secreting tumor called pheochromocytoma. This tumor arises when the chromaffin cells of the adrenal gland fail to involute and the excess production can cause life­threatening hypertension, tachycardia, diapho­

resis, tremors, and headaches (Kline­Tilford, 2016).

Diagnosis is made through measurements of meta­

nephrine and catecholamine levels and urine vanil­

lylmandelic acid (VMA). Hypertension control is imperative and is often initially done with alpha­

and beta­blocker infusions with subsequent tumor resection. Care must be taken, however, to avoid using beta­blockers alone as unopposed alpha activ­

ity could occur.

CLINICAL ASSESSMENT OF ENDOCRINE FUNCTION

Many endocrine disorders develop slowly over time and often go unrecognized by those (parents and care­

givers) with daily contact with the child. Assessment through careful history, documentation of past medical conditions, growth patterns, developmental milestones, physical exam findings, and family history are critical to the accurate diagnosis of specific endocrine disorders.